ROBOTIC GASTRIC BYPASS: THE FUTURE OF BARIATRIC SURGERY
Objective:
Compare robotic versus laparoscopic roux-en-Y gastric bypass (RYGB) for the
treatment of morbid obesity in a community hospital.
Introduction:
Since receiving Food and
Drug Administration approval in 2000, surgery utilizing a robot (da Vinci®
Surgical System) has been successfully performed in numerous procedures
including RYGB.
In addition, there are
limited studies with relatively small sample sizes that have compared robotic vs. laparoscopic RYGB in the literature.
Methods:
Through a retrospective analysis of a prospectively collected database, we compared outcomes and
complication rates of robotic vs. laparoscopic RYGB in the treatment of morbid
obesity.
Outcomes data included
weight loss, operative times, and hospital length of stay. All complications encountered
by both groups were reported.
Results:
Eightypatients who
underwent robotic RYGB were compared to 80 patients who received laparoscopic
RYGB. Rate of weight loss and reduction in body mass index (BMI) over time were
similar in both groups. There were no mortalities in either group.
Hospital length of stay and operative times were
similar in both groups, but there was a trend towards a shorter length of stay
with robotic
RYGB.
Comments
Post a Comment